PECAM1 and relapsing-remitting multiple sclerosis: In patients with relapsing-remitting MS, elevated serum levels of soluble PECAM-1 (33, 34), increased numbers of circulating PECAM-1-positive microparticles (35) as well as increased expression of PECAM-1 on circulating leukocytes (36) have been observed.